Martin Buckland
Directeur Général chez Astex Pharmaceuticals, Inc.
Profil
Martin Buckland is currently the Chief Executive Officer at Astex Pharmaceuticals, Inc. and a Member at The Royal Institution of Chartered Surveyors.
Previously, he held positions such as Director-Sales & Marketing at ADAS Consulting Ltd., Chief Business Officer & Director at Astex Therapeutics Ltd., Vice President at Xenova Group Plc, Chief Business Officer at SuperGen, Inc., Principal at Celltech Group Plc, Vice President-Periclinical Services at Quintiles, Inc. (California), and Vice President-Global Business Development at Elan Pharmaceuticals, LLC.
Dr. Buckland obtained his undergraduate and doctorate degrees from the University of Oxford and holds an MBA from The Open University and The Open University Business School.
Postes actifs de Martin Buckland
| Sociétés | Poste | Début |
|---|---|---|
The Royal Institution of Chartered Surveyors
 The Royal Institution of Chartered Surveyors Miscellaneous Commercial ServicesCommercial Services The Royal Institution of Chartered Surveyors provides professional excellence in its membership through education, accreditation, publication, and other services. The non-profit company is based in London, UK, and has a global presence of subsidiaries in several regions. Justin Young has been the CEO of the British company since 2023. | Corporate Officer/Principal | 09/11/2010 |
Astex Pharmaceuticals, Inc.
 Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA. | Directeur Général | 01/07/2011 |
Anciens postes connus de Martin Buckland
| Sociétés | Poste | Fin |
|---|---|---|
SuperGen, Inc.
 SuperGen, Inc. Pharmaceuticals: MajorHealth Technology SuperGen, Inc. researches and develops drugs, diagnostics and other therapeutic products. It discovers and develops novel cancer therapies and drugs. SuperGen buys rights to drugs in advanced stages of development and bring them to market. The company's major product is Nipent it is used for graft-versus-host disease, which afflicts bone marrow transplant recipients and various forms of lymphoma. SuperGen also makes a few generic cancer drugs like paclitaxel. The company was founded on March 6, 1991 by David M Fineman and Elliott L. Fineman and is headquartered in Dublin, CA. | Corporate Officer/Principal | 13/09/2011 |
ADAS Consulting Ltd.
 ADAS Consulting Ltd. Chemicals: AgriculturalProcess Industries ADAS Consulting Ltd. provides agricultural development and services. Its services include agricultural advice, animal health and welfare, crop management. ADAS Consulting is headquartered in Wolverhampton, the united kingdom. | Sales & Marketing | - |
Celltech Group Plc
 Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Corporate Officer/Principal | - |
Xenova Group Plc
 Xenova Group Plc Miscellaneous Commercial ServicesCommercial Services Xenova Group Plc researches and develops pharmaceutical products. The company is focused on the development of novel drugs to treat cancer and addiction with a secondary focus in immunotherapy. It has pipeline of drug candidates in clinical development including a novel program for the treatment of high-grade glioma and TransMID. The company was founded in 1987 and is headquartered in Slough, UK | Corporate Officer/Principal | - |
Quintiles, Inc. (California)
 Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | - |
Formation de Martin Buckland
| University of Oxford | Doctorate Degree |
| The Open University | Masters Business Admin |
| The Open University Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Astex Therapeutics Ltd.
 Astex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Astex Therapeutics Ltd. engages in the provision of drug discovery and development activities. Its proprietary fragment-based drug discovery platform, Pyramid, delivers drug leads on therapeutic targets and disease areas.The company was founded by Harren Jhotin, Roberto Solari, Stephen W. Bunting, Christopher Abell, and Thomas L. Blundell in 1999 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Health Technology |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Health Services |
Xenova Group Plc
Xenova Group Plc Miscellaneous Commercial ServicesCommercial Services Xenova Group Plc researches and develops pharmaceutical products. The company is focused on the development of novel drugs to treat cancer and addiction with a secondary focus in immunotherapy. It has pipeline of drug candidates in clinical development including a novel program for the treatment of high-grade glioma and TransMID. The company was founded in 1987 and is headquartered in Slough, UK | Commercial Services |
Celltech Group Plc
Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Health Technology |
ADAS Consulting Ltd.
ADAS Consulting Ltd. Chemicals: AgriculturalProcess Industries ADAS Consulting Ltd. provides agricultural development and services. Its services include agricultural advice, animal health and welfare, crop management. ADAS Consulting is headquartered in Wolverhampton, the united kingdom. | Process Industries |
The Royal Institution of Chartered Surveyors
The Royal Institution of Chartered Surveyors Miscellaneous Commercial ServicesCommercial Services The Royal Institution of Chartered Surveyors provides professional excellence in its membership through education, accreditation, publication, and other services. The non-profit company is based in London, UK, and has a global presence of subsidiaries in several regions. Justin Young has been the CEO of the British company since 2023. | Commercial Services |
SuperGen, Inc.
SuperGen, Inc. Pharmaceuticals: MajorHealth Technology SuperGen, Inc. researches and develops drugs, diagnostics and other therapeutic products. It discovers and develops novel cancer therapies and drugs. SuperGen buys rights to drugs in advanced stages of development and bring them to market. The company's major product is Nipent it is used for graft-versus-host disease, which afflicts bone marrow transplant recipients and various forms of lymphoma. SuperGen also makes a few generic cancer drugs like paclitaxel. The company was founded on March 6, 1991 by David M Fineman and Elliott L. Fineman and is headquartered in Dublin, CA. | Health Technology |
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded on May 28, 1997 and is headquartered in Pleasanton, CA. | Health Technology |
